StockNews.com initiated coverage on shares of Applied DNA Sciences (NASDAQ:APDN - Free Report) in a research report sent to investors on Monday morning. The brokerage issued a sell rating on the technology company's stock.
Applied DNA Sciences Price Performance
NASDAQ:APDN traded down $0.14 during mid-day trading on Monday, hitting $1.79. 2,430,407 shares of the company's stock were exchanged, compared to its average volume of 216,691. The company has a market cap of $1.98 million, a PE ratio of -0.31 and a beta of 0.43. Applied DNA Sciences has a one year low of $1.67 and a one year high of $506.40. The business has a fifty day moving average price of $7.51 and a 200 day moving average price of $17.65.
Applied DNA Sciences (NASDAQ:APDN - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The technology company reported ($28.00) EPS for the quarter, missing analysts' consensus estimates of ($16.00) by ($12.00). Applied DNA Sciences had a negative return on equity of 101.57% and a negative net margin of 228.12%. On average, equities analysts forecast that Applied DNA Sciences will post -0.87 EPS for the current fiscal year.
Hedge Funds Weigh In On Applied DNA Sciences
Hedge funds have recently bought and sold shares of the company. Jane Street Group LLC purchased a new position in Applied DNA Sciences in the third quarter worth about $48,000. Millennium Management LLC bought a new stake in shares of Applied DNA Sciences during the fourth quarter valued at approximately $28,000. Connective Capital Management LLC bought a new stake in shares of Applied DNA Sciences during the fourth quarter valued at approximately $36,000. Finally, Geode Capital Management LLC raised its holdings in Applied DNA Sciences by 291.1% in the 4th quarter. Geode Capital Management LLC now owns 417,485 shares of the technology company's stock worth $85,000 after acquiring an additional 310,749 shares during the last quarter. Institutional investors own 22.22% of the company's stock.
About Applied DNA Sciences
(
Get Free Report)
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Further Reading
Before you consider Applied DNA Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Applied DNA Sciences wasn't on the list.
While Applied DNA Sciences currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
